联泓新科(003022.SZ)：2025年三季报净利润为2.32亿元、同比较去年同期上涨30.32%

Core Insights - The company reported a total revenue of 4.568 billion yuan for Q3 2025, with a net profit attributable to shareholders of 232 million yuan, reflecting an increase of 54.071 million yuan or 30.32% year-on-year [1] Financial Performance - Operating cash flow was 261 million yuan [1] - The latest debt-to-asset ratio stands at 64.84% [1] - Gross margin improved to 19.47%, up by 4.14 percentage points compared to the same period last year [1] - Return on equity (ROE) increased to 3.15%, a rise of 0.67 percentage points year-on-year [1] - Diluted earnings per share reached 0.17 yuan, an increase of 0.04 yuan or 30.77% year-on-year [1] - Total asset turnover ratio is 0.22 times, while inventory turnover ratio is 5.49 times [1] Shareholder Structure - The number of shareholders is 64,800, with the top ten shareholders holding 1.08 billion shares, accounting for 80.89% of total equity [1] - Major shareholders include: - Lianhong Group Co., Ltd. with 487 million shares - Chinese Academy of Sciences Holdings Co., Ltd. with 252 million shares - Tibet Lianhong Sheng Enterprise Management Partnership (Limited Partnership) with 30.6 million shares [1]